U.S. flag

An official website of the United States government

GTR Home > Tests > PGx-ADHD

Overview

Test order codeHelp: SGH010

Test name

Help

PGx-ADHD

Purpose of the test

Help

This is a clinical test intended for Help: Drug Response

Condition

Help

Click Indication tab for more information.

How to order

Help

Not provided

Methodology

Help
Molecular Genetics
TTargeted variant analysis
SNP Detection

Summary of what is tested

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Practice guidelines

  • DailyMed Drug Label, 2022
    DailyMed Drug Label, ATOMOXETINE capsule, 2022
  • DPWG, 2022
    Royal Dutch Pharmacists Association (KNMP). Dutch Pharmacogenetics Working Group (DPWG). Pharmacogenetic Recommendation.
  • DailyMed Drug Label, 2022
    DailyMed Drug Label, atomoxetine, 2022
  • CPIC, 2019
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy
  • DPWG, 2011
    Pharmacogenetics: from bench to byte--an update of guidelines.
  • NACB, 2010
    National Academy of Clinical Biochemistry, Clinical practice considerations. In: Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice, 2010

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.